Consumer Health

In 2023, meal replacement and weight loss supplements are projected to record healthy increases in retail volume sales. Dutch consumers are becoming more aware of the health risks involved with obesity. Awareness was heightened by the Coronavirus…

Sales of wound care continue to recover in 2023 from the losses seen during the pandemic. The warm and relatively dry weather in the spring and early 2023 was good for sales. Good weather generally encourages more outdoor activities thereby…

After declining sales during the pandemic due to limited outdoor and physical activity, sticking plasters/adhesive bandages, first-aid kits and gauze, tape and other wound care saw positive volume growth in 2022 and again in 2023 as consumers…

2023 has seen an upturn in demand for wound care in France. During lockdown, public spaces, such as sports centres, outdoor activity locations and parks among others, were closed. Unable to take part in various activities, consumers were less likely…

The wound care category has been subject to price hikes in 2022 and 2023 in the context of high rates of inflation and hikes in production and transport costs. Wound care is not subject to the same regulatory framework as other OTC products and,…

Consumers lifestyles have shifted back to normality in 2023, with individuals spending more time outside the home and doing more team sports. This has generated a greater need for quick and convenient solutions for minor traumas, including sticking…

Wound care is set to see moderate growth in current value and retail volume terms in 2023. Sales are benefiting from Italian consumers returning to their old pre-pandemic lifestyles with there being a growing desire to spend time outside pursuing…

2023 saw wound care record positive volume sales growth for the second consecutive year after declining sales were registered at the peak of the COVID-19 pandemic during 2020 and 2021. With the post-pandemic era defined by a return to normal daily…

Wound care is projected to see a steady increase in retail volume sales throughout 2023, accompanied by an even more significant increase in retail current value terms. The category is performing well as it continues to recover from strong declines…

Analgesics has experienced a fluctuating performance in the last few years, as demand has been significantly impacted by the dramatic changes to consumer lifestyles resulting from the COVID-19 crisis. With the outbreak of COVID-19 in 2020, many…

Analgesics recorded a significant increase in retail volume terms in 2021 and this was followed by even more dynamic growth in 2022. The COVID-19 pandemic and the tough restrictions introduced in 2020 and the beginning of 2021 in order to prevent it…

Since 2020, a factor supporting the growth of analgesics was the increased tendency of doctors to prescribe acetaminophen, among other common types of analgesics, as a way of managing the symptoms of patients with COVID-19, including muscle and joint…

Consumer health in Finland is seeing moderate current value growth in 2023. On one hand, prices have increased due to inflation, but, at the same time, the poor economic outlook has made consumers cautious in their purchases. Overall, the OTC segment…

Overall, consumer health in Portugal is set to record strong growth in retail volume and current value terms in 2023. Demand has remained robust, as local consumers remain health-conscious and are becoming increasingly knowledgeable about the…

Retail volume sales of some consumer health products in 2023 are declining following a surge in demand the previous year when pandemic-related restrictions in April 2022 resulted in Spaniards returning to some extent to their pre-pandemic lives. This…

Cough, cold and allergy (hay fever) sales are expected to be slightly down in 2023. This is partly a result of the very strong performance seen in the previous year, as the lifting of COVID-19 related restrictions led to greater social contact and…

During the winters 2020/2021 and 2021/2022, the circulation of cough, cold and flu viruses was limited by the restrictions implemented to contain the COVID-19 pandemic. Winter 2022/2023 was the first one with no restrictions in place at all and this…

After the surge in sales that cough, cold and allergy (hay fever) remedies experienced in 2022, demand is waning in 2023, with the category recording more subdued growth rates. Traditionally, sales of cough, cold and allergy (hay fever) remedies in…

Healthy growth in dermatologicals is stemming from launches of value-added products. There was a pause on most new product development activity during the COVID-19 crisis, but with the end of the pandemic, products that had been held back have been…

Dermatologicals is set to register positive growth in current value and retail volume terms in 2023. With the WHO declaring the pandemic to be over in May 2023, there has been an increase in socialisation and physical contact between people which has…